Nestlé’s history gives people plenty of legitimate reasons to question the company’s priorities. We do not need to invent another one.
Wobenzym was widely respected as a systemic enzyme formula for joint discomfort, inflammation, swelling, and physical recovery. Nestlé acquired Atrium Innovations, the company whose portfolio included Wobenzym, in 2017. Years later, Wobenzym N disappeared from much of the North American market, leaving longtime patients and practitioners without a product they had trusted for decades.
There is no confirmed evidence that Nestlé discontinued it because it “worked too well.” That allegation cannot honestly be presented as fact. What can be said is that a highly regarded, clinically studied product became unavailable to many customers after passing through the hands of one of the largest corporations in the world, with little public explanation that satisfied those who depended upon it.
That alone deserves scrutiny.
This is also the corporation whose former chairman once called the idea of declaring water a universal public right an “extreme” position. He later clarified that basic drinking water and sanitation should be protected as human rights, while arguing that water used beyond those basic needs should carry a market value.
So criticize Nestlé. Question its decisions. Examine its record. There is more than enough documented history to justify doing so.
But the strongest argument is always the one that cannot be dismissed because the facts are wrong.
davidorman.com 